Services
Online Inquiry
For research use only. Not intended for any clinical use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Non-Human Primate (NHP) Receptor Occupancy (Flow Cytometry) Service
Are you currently facing complex challenges in biopharmaceutical development, such as ensuring precise dose selection in clinical trials or validating target engagement in preclinical models? Our NHP Receptor Occupancy Service helps you gain critical insights and streamline your project timelines through advanced, high-precision flow cytometry technology. We provide comprehensive data that bridges the gap between pharmacokinetics and pharmacodynamics, empowering you to make confident, data-driven decisions.
Introduction of Our NHP Receptor Occupancy Service
Non-human primates (NHPs) are a key model in biopharmaceutical development due to their high genetic and immunological similarity to humans. This makes them invaluable for accurately predicting drug efficacy and safety. NHP Receptor Occupancy (RO) assays, powered by flow cytometry, are a powerful pharmacodynamic (PD) biomarker that quantifies the binding of a therapeutic agent to its cellular target. By measuring the percentage of occupied receptors, we provide the essential data needed to establish a clear relationship between the drug's concentration and its biological effect.
What Our Service Is
Our service provides a comprehensive solution for measuring the binding of therapeutic antibodies and biologics to their target receptors on the surface of NHP cells. This critical data is used to inform key decisions throughout the drug development lifecycle. We offer three primary assay formats to suit your specific needs:
| Free Receptor Assays | Bound Receptor Assays | Total Receptor Assays |
| Measures the receptors on the cell surface that are not yet bound by the therapeutic drug, providing insight into the drug's availability. | Detects and quantifies receptors that are already occupied by the therapeutic agent. | Determines the total number of receptors expressed on the cell surface, both bound and unbound. |
These services are widely used in critical stages, including:
- Dose Selection and Optimization: Establishing the optimal dose for first-in-human studies by correlating dose with receptor saturation.
- PK/PD Modeling: Integrating RO data with PK profiles to create robust predictive models that guide clinical decisions.
- Mechanism of Action (MOA) Studies: Providing quantitative evidence that your therapeutic is engaging its target as intended.
Why Choose Us?
Navigating the complexities of RO assay development can lead to delays and unreliable data. Without an experienced partner, you may face challenges with reagent selection, sample stability, and data normalization, which can compromise your project timeline and data quality. Creative Biolabs provides a seamless solution. We transform these pain points into tangible benefits:
-
Pain Point: Complex assay development and validation.
- Benefit: We provide a "fit-for-purpose" approach, ensuring a robust, validated assay that is tailored to your specific molecule and project needs, saving you time and resources.
-
Pain Point: Delays in obtaining results for critical decisions.
- Benefit: Our streamlined workflow and dedicated team provide rapid turnaround times, helping you accelerate your development timeline and maintain momentum.
Distributed under Unsplash License, from Unsplash.
Key Benefits of Our Service
Creative Biolabs' NHP Receptor Occupancy Service is built on a foundation of scientific rigor and operational excellence, ensuring your project succeeds.
- Proprietary NHP Resources: Our access to a diverse and well-characterized colony of non-human primates allows for seamless sample acquisition. This ensures the consistency and quality of starting materials, which is crucial for reproducible RO data.
- Customization and Flexibility: Every molecule is unique. We specialize in designing and validating custom, multi-parameter flow cytometry panels to precisely measure your therapeutic's binding to its target. This includes navigating complex scenarios such as receptor internalization or shedding.
- Unparalleled Reporting Depth: Our deliverables go beyond raw data. Our expert bioinformaticians provide detailed, easy-to-interpret reports that include comprehensive data normalization and analysis, providing a clear picture of your therapeutic's performance.
How Creative Biolabs' NHP Receptor Occupancy Can Assist Your Project?
We provide a clear path from project initiation to actionable results, ensuring a seamless and transparent process for our clients. We work to provide precise, high-quality data to advance your drug development program.
01
Required Starting Materials
02
Project Consultation & Assay Design
03
Pilot Studies & Assay Validation
04
Sample Processing & Analysis
05
Data Processing & Normalization
06
Final Data Delivery & Reporting
Key Deliverables
- Detailed Final Study Report
- Complete Raw Flow Cytometry Data
- Comprehensive Data Analysis with graphical summaries
- Customized Method Development and Validation Reports
- Raw Data
- Final Report
Capabilities & Partnerships
Service-Specific Data
- Annual Sample Size: Over 50,000 samples analyzed per year.
- Turnaround Time (TAT): Typical turnaround of 2 weeks for bioanalytical results.
- Study Pass Rate: 99%+ success rate in meeting study endpoints.
Our Valued Partners
Frequently Asked Questions
Q: Why are NHP models preferred for this service?
A: NHP models are widely used because they share a high degree of genetic and immunological similarity with humans, making them an ideal translational model for biotherapeutics. Data from NHP studies provides a stronger basis for predicting drug behavior in human clinical trials, which is critical for making confident go/no-go decisions.
Q: What if our therapeutic causes receptor internalization?
A: Receptor internalization is a common challenge in RO assays. Our expert team specializes in designing assays that can accurately account for these events. We use specific antibodies and controls to differentiate between bound receptors and internalized ones, ensuring your data reflects the true binding dynamics of your therapeutic.
Q: Can your assays handle complex, multi-parameter studies?
A: Absolutely. Our flow cytometry platform is capable of high-parameter analysis, allowing us to simultaneously measure receptor occupancy, cell phenotype, and other biomarkers. This provides a completer and more accurate picture of your therapeutic's impact within a complex biological system.
Q: How does your service compare to traditional binding assays like ELISA?
A: While ELISA is a useful tool, flow cytometry allows receptor occupancy analysis across specific cell populations within heterogeneous samples. This provides more precise target engagement data than traditional bulk assays.
Contact Us
Creative Biolabs is your trusted partner for NHP Receptor Occupancy services. Our scientific expertise, advanced technology, and commitment to quality ensure that you receive the precise, reliable data you need to accelerate your biopharmaceutical development program. To learn more about how our NHP Receptor Occupancy service can be tailored to your specific project needs, please reach out to our team of experts.